Literature DB >> 32702754

Red cell membrane disorders: structure meets function.

Mary Risinger1, Theodosia A Kalfa2,3.   

Abstract

The mature red blood cell (RBC) lacks a nucleus and organelles characteristic of most cells, but it is elegantly structured to perform the essential function of delivering oxygen and removing carbon dioxide from all other cells while enduring the shear stress imposed by navigating small vessels and sinusoids. Over the past several decades, the efforts of biochemists, cell and molecular biologists, and hematologists have provided an appreciation of the complexity of RBC membrane structure, while studies of the RBC membrane disorders have offered valuable insights into structure-function relationships. Within the last decade, advances in genetic testing and its increased availability have made it possible to substantially build upon this foundational knowledge. Although disorders of the RBC membrane due to altered structural organization or altered transport function are heterogeneous, they often present with common clinical findings of hemolytic anemia. However, they may require substantially different management depending on the underlying pathophysiology. Accurate diagnosis is essential to avoid emergence of complications or inappropriate interventions. We propose an algorithm for laboratory evaluation of patients presenting with symptoms and signs of hemolytic anemia with a focus on RBC membrane disorders. Here, we review the genotypic and phenotypic variability of the RBC membrane disorders in order to raise the index of suspicion and highlight the need for correct and timely diagnosis.
© 2020 by The American Society of Hematology.

Entities:  

Year:  2020        PMID: 32702754      PMCID: PMC7483429          DOI: 10.1182/blood.2019000946

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  106 in total

Review 1.  The Gárdos channel: a review of the Ca2+-activated K+ channel in human erythrocytes.

Authors:  Anthony D Maher; Philip W Kuchel
Journal:  Int J Biochem Cell Biol       Date:  2003-08       Impact factor: 5.085

Review 2.  Abnormalities of the erythrocyte membrane.

Authors:  Patrick G Gallagher
Journal:  Pediatr Clin North Am       Date:  2013-10-15       Impact factor: 3.278

3.  Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel.

Authors:  Raphael Rapetti-Mauss; Olivier Soriani; Henri Vinti; Catherine Badens; Hélène Guizouarn
Journal:  Haematologica       Date:  2016-07-21       Impact factor: 9.941

4.  Analysis of factors regulating erythrocyte deformability.

Authors:  N Mohandas; M R Clark; M S Jacobs; S B Shohet
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

5.  Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome.

Authors:  Joanna F Flatt; Hélène Guizouarn; Nicholas M Burton; Franck Borgese; Richard J Tomlinson; Robert J Forsyth; Stephen A Baldwin; Bari E Levinson; Philippe Quittet; Patricia Aguilar-Martinez; Jean Delaunay; Gordon W Stewart; Lesley J Bruce
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

6.  Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter.

Authors:  Connie M Westhoff; Michelle Ferreri-Jacobia; Don-On Daniel Mak; J Kevin Foskett
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

7.  Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis.

Authors:  Ryan Zarychanski; Vincent P Schulz; Brett L Houston; Yelena Maksimova; Donald S Houston; Brian Smith; Jesse Rinehart; Patrick G Gallagher
Journal:  Blood       Date:  2012-04-23       Impact factor: 22.113

8.  Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Authors:  Kenneth I Ataga; Marvin Reid; Samir K Ballas; Zahida Yasin; Carolyn Bigelow; Luther St James; Wally R Smith; Frederic Galacteros; Abdullah Kutlar; James H Hull; Jonathan W Stocker
Journal:  Br J Haematol       Date:  2011-02-17       Impact factor: 6.998

9.  Molecular basis and functional consequences of the dominant effects of the mutant band 3 on the structure of normal band 3 in Southeast Asian ovalocytosis.

Authors:  Hiroyuki Kuma; Yoshito Abe; David Askin; Lesley J Bruce; Tomohiro Hamasaki; Michael J A Tanner; Naotaka Hamasaki
Journal:  Biochemistry       Date:  2002-03-12       Impact factor: 3.162

10.  Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients.

Authors:  Immacolata Andolfo; Roberta Russo; Barbara Eleni Rosato; Francesco Manna; Antonella Gambale; Carlo Brugnara; Achille Iolascon
Journal:  Am J Hematol       Date:  2018-10-02       Impact factor: 10.047

View more
  10 in total

1.  Diagnosis and clinical management of red cell membrane disorders.

Authors:  Theodosia A Kalfa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  The Piezo1 ion channel in glaucoma: a new perspective on mechanical stress.

Authors:  Ying Su; Feng Wang; Yidan Chen
Journal:  Hum Cell       Date:  2022-06-29       Impact factor: 4.374

3.  Structure, dynamics and assembly of the ankyrin complex on human red blood cell membrane.

Authors:  Xian Xia; Shiheng Liu; Z Hong Zhou
Journal:  Nat Struct Mol Biol       Date:  2022-06-02       Impact factor: 18.361

Review 4.  Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia.

Authors:  Hee Won Chueh; Sang Mee Hwang; Ye Jee Shim; Jae Min Lee; Hee Sue Park; Joon Hee Lee; Youngwon Nam; Namhee Kim; Hye Lim Jung; Hyoung Soo Choi
Journal:  Blood Res       Date:  2022-05-20

5.  Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).

Authors:  Omar Niss; Robert B Lorsbach; Mikaela Berger; Satheesh Chonat; Morgan McLemore; David Buchbinder; Timothy McCavit; Linda G Shaffer; Jessica Simpson; Jeffrey H Schwartz; Jessica Meznarich; Myesa Emberesh; Katie G Seu; Wenying Zhang; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2020-12-24       Impact factor: 3.039

6.  Red blood cell recognition and posture estimation in microfluidic chip based on lensless imaging.

Authors:  Jianwei Li; Li Dai; Ningmei Yu; Yinfeng Wu
Journal:  Biomicrofluidics       Date:  2021-05-28       Impact factor: 3.258

Review 7.  Autoimmune Hemolytic Anemia in the Pediatric Setting.

Authors:  Aikaterini Voulgaridou; Theodosia A Kalfa
Journal:  J Clin Med       Date:  2021-01-09       Impact factor: 4.241

8.  Rare anemias in adolescents.

Authors:  Joan Lluis Vives-Corrons; Elena Krishnevskaya
Journal:  Acta Biomed       Date:  2021-02-18

9.  Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia.

Authors:  Alina Sadaf; Katie G Seu; Elizabeth Thaman; Rose Fessler; Diamantis G Konstantinidis; Holly A Bonar; Jennifer Korpik; Russell E Ware; Patrick T McGann; Charles T Quinn; Theodosia A Kalfa
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

10.  The Post-Storage Performance of RBCs from Beta-Thalassemia Trait Donors Is Related to Their Storability Profile.

Authors:  Alkmini T Anastasiadi; Efthymios C Paronis; Vasiliki-Zoi Arvaniti; Athanasios D Velentzas; Anastasia C Apostolidou; Evangelos G Balafas; Monika Dzieciatkowska; Nikolaos G Kostomitsopoulos; Konstantinos Stamoulis; Issidora S Papassideri; Angelo D'Alessandro; Anastasios G Kriebardis; Marianna H Antonelou; Vassilis L Tzounakas
Journal:  Int J Mol Sci       Date:  2021-11-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.